Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 20683883)

Published in J Bone Miner Res on November 01, 2010

Authors

Barbara M Misof1, Eleftherios P Paschalis, Stéphane Blouin, Nadja Fratzl-Zelman, Klaus Klaushofer, Paul Roschger

Author Affiliations

1: Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 4th Medical Department, Hanusch Hospital, Vienna, Austria. barbara.misof@osteologie.at

Articles citing this

Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab (2013) 0.98

Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH 1-34 treatment. Bone (2014) 0.86

Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women. Calcif Tissue Int (2014) 0.85

Quantifying mineralization using bone mineral density distribution in the mandible. J Craniofac Surg (2012) 0.80

PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization. J Bone Miner Res (2015) 0.80

Teriparatide Improves Fracture Healing and Early Functional Recovery in Treatment of Osteoporotic Intertrochanteric Fractures. Medicine (Baltimore) (2016) 0.79

Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study. Osteoporos Int (2015) 0.76

Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration. Osteoporos Int (2016) 0.76

Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone (2013) 0.75

Presence of pyrophosphate in bone from an atypical femoral fracture site: A case report. Bone Rep (2017) 0.75

Treatment of osteoporosis after alendronate or risedronate. Osteoporos Int (2015) 0.75

Articles by these authors

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2010) 6.00

Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2013) 5.76

From brittle to ductile fracture of bone. Nat Mater (2005) 2.76

Nanoscale deformation mechanisms in bone. Nano Lett (2005) 2.48

COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta. Hum Mutat (2011) 1.77

Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment. J Bone Miner Res (2010) 1.61

Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ (2005) 1.60

Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis. J Clin Endocrinol Metab (2004) 1.53

Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. Bone (2013) 1.52

Sclerostin deficiency is linked to altered bone composition. J Bone Miner Res (2014) 1.49

Mineralization pattern of vertebral bone material following fragility fracture of the spine. J Orthop Res (2012) 1.43

Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab (2003) 1.38

Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res (2006) 1.32

Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res (2006) 1.20

In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res (2002) 1.17

Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone (2005) 1.13

Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J Biol Chem (2010) 1.12

X-ray vector radiography for bone micro-architecture diagnostics. Phys Med Biol (2012) 1.11

The organization of the osteocyte network mirrors the extracellular matrix orientation in bone. J Struct Biol (2010) 1.10

Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment. J Bone Miner Res (2010) 1.04

New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. J Bone Miner Res (2007) 1.04

Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations. Calcif Tissue Int (2008) 1.02

Bone material properties in premenopausal women with idiopathic osteoporosis. J Bone Miner Res (2012) 1.00

Spectroscopically determined collagen Pyr/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinant congenic mice with divergent calculated bone tissue strength. Connect Tissue Res (2003) 1.00

[Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009]. Wien Med Wochenschr Suppl (2009) 0.99

Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Calcif Tissue Int (2007) 0.99

Persistent torticollis, facial asymmetry, grooved tongue, and dolicho-odontoid process in connection with atlas malformation complex in three family subjects. Eur Spine J (2007) 0.98

Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab (2011) 0.98

Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun (2003) 0.98

Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta. Bone (2006) 0.98

Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. Bone (2009) 0.97

Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid. J Bone Miner Res (2011) 0.97

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J Bone Miner Res (2009) 0.95

DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells. Epigenetics (2012) 0.93

Mortality after hip fracture in Austria 2008-2011. Calcif Tissue Int (2014) 0.92

Spinal and pelvic corrections in a patient with spondylocostal dysplasia syndrome and hemimyelomeningocele. Afr J Paediatr Surg (2014) 0.92

Atlanto-axial segmentation defects and os odontoideum in two male siblings with opsismodysplasia. Skeletal Radiol (2008) 0.91

Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. J Bone Miner Res (2014) 0.90

Asymmetrical skull, ptosis, hypertelorism, high nasal bridge, clefting, umbilical anomalies, and skeletal anomalies in sibs: is Carnevale syndrome a separate entity? Am J Med Genet A (2007) 0.90

Changes in the degree of mineralization with osteoporosis and its treatment. Curr Osteoporos Rep (2014) 0.89

Low bone mineral density and fragility fractures in permanent vegetative state patients. J Bone Miner Res (2014) 0.89

Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis. J Bone Miner Res (2011) 0.89

Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. J Bone Miner Res (2008) 0.89

Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Kidney Int (2003) 0.89

Osteochondritis dissecans and Osgood Schlatter disease in a family with Stickler syndrome. Pediatr Rheumatol Online J (2009) 0.88

Professional awareness is needed to distinguish between child physical abuse from other disorders that can mimic signs of abuse (Skull base sclerosis in infant manifesting features of infantile cortical hyperostosis): a case report and review of the literature. Cases J (2009) 0.88

Craniocervical junction malformation in a child with Oromandibular-limb hypogenesis-Möbius syndrome. Orphanet J Rare Dis (2007) 0.88

Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy study. J Bone Miner Res (2014) 0.87

Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate. Bone (2011) 0.87

Caudal regression syndrome and popliteal webbing in connection with maternal diabetes mellitus: a case report and literature review. Cases J (2008) 0.87

Windswept lower limb deformities in patients with hypophosphataemic rickets. Swiss Med Wkly (2013) 0.87

Cortical and trabecular bone density in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab (2013) 0.87

Altered bone matrix mineralization in a patient with Rett syndrome. Bone (2010) 0.86

Extra-cellular matrix suppresses expression of the apoptosis mediator Fas by epigenetic DNA methylation. Apoptosis (2010) 0.86

Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover. Calcif Tissue Int (2011) 0.85

Treatment of varus deformities of the lower limbs in patients with achondroplasia and hypochondroplasia. Open Orthop J (2013) 0.85

Biomimetic mineral-organic composite scaffolds with controlled internal architecture. J Mater Sci Mater Med (2005) 0.85